We validated the increased expression of these genes in clinical specimens of ALCL, showing that expression levels were increased ~10-fold for BMS1P20, ~17-fold for LINC01013, ~19-fold for MIR503HG, ~5-fold for CACNA1G-AS1 and ~15-fold for RNF144A-AS1 (Fig. 1b). The gene discussed is RNF144A; the disease is anaplastic large cell lymphoma.